Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000049777 | SCV004202516 | pathogenic | Lysinuric protein intolerance | 2023-09-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000049777 | SCV004296551 | pathogenic | Lysinuric protein intolerance | 2023-03-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser72Trpfs*97) in the SLC7A7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC7A7 are known to be pathogenic (PMID: 10631139, 17764084). For these reasons, this variant has been classified as Pathogenic. This variant is also known as 455delCTCT. This premature translational stop signal has been observed in individual(s) with lysinuric protein intolerance (PMID: 10631139). This variant is not present in population databases (gnomAD no frequency). |
Fulgent Genetics, |
RCV000049777 | SCV005636725 | pathogenic | Lysinuric protein intolerance | 2024-04-09 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049777 | SCV000082184 | probable-pathogenic | Lysinuric protein intolerance | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |